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 Men who have sex with men (MSM) have been consistently burdened by human 
immunodeficiency virus (HIV) at higher rates than adults in the general population.  Cameroon has a 
large MSM population throughout its major cities.  Though PrEP has been shown to reduce infections in 
MSM populations, it has yet to be introduced in Cameroon.  This study uses a mathematical model to 
simulate population level HIV transmission in Cameroon among MSM.  PrEP is incorporated into the 
model to assess the effects to HIV prevalence and prevented infections.  The model simulated an HIV 
prevalence of 16.4%, annual diagnoses of 946 infections per 100,000 MSM and antiretroviral (ART) 
coverage of 74.2%.  PrEP as a standalone intervention at 10% and 20% intervention resulted in HIV 
prevalence decreasing by 3.8% and 5.4% over a 20-year intervention, respectively. A 10% increase in 
HIV testing combined with a PrEP intervention at 10% initiation resulted in prevalence being reduced 
even further, by 5.0% to 11.4%.  This same intervention reduced the percentage of infected individuals 
that were unaware of their status from 15.6% to 6.7%.  The interventions with the largest effect in 
reducing prevalence were the combination of PrEP and increased HIV testing.  PrEP was beneficial to 
reducing prevalence and preventing infections even at low initiation and coverage levels. 
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The Human Immunodeficiency Virus (HIV) pandemic continues to expand among men who have 
sex with men (MSM), despite declining in most other populations1-3.  Studies from high-income countries 
suggest that MSM are at greater risk of infection, while MSM in low and middle income countries may 
face high levels of stigma and may have limited access to interventions4,5.  Using pre-exposure 
prophylaxis (PrEP) as a means of preventing HIV has been shown to prevent new infections in MSM6.  
Mathematical model studies can provide valuable insight into the possible impacts of interventions. 
HIV-negative individuals can use antiretroviral therapy (ART) to protect themselves against 
getting infected with HIV, called PrEP.  PrEP has been tested in many forms, a vaginal microbicide gel 
comprised of 1% tenofovir was tested among a cohort of women in South Africa.  It prevented 39% of 
infections overall and over 50% in individuals with high adherence.  Use of a dapivirine vaginal ring has 
been used more recently with a decrease in incidence of 37% compared to placebo7.  Though one trial 
using oral PrEP failed to provide any efficacy in a cohort of women in South Africa and Kenya, it remains 
the only trial to date that did not protect against infection8.  The Pre-Exposure Prophylaxis Initiative 
(iPrEx) tested oral PrEP as a standalone intervention among MSM and transgender women and found a 
44% reduction in incidence6.  Oral PrEP has proven safety and efficacy in MSM populations. 
 In large part due to these prevention resources, there has been an increase in optimism 
surrounding the control of the HIV pandemic, though MSM epidemics continue to grow.  HIV prevalence 
among MSM remains high in many regions of the world such as the Caribbean, where prevalence is 
roughly 25%. HIV prevalence among MSM is around 15-18% in Sub-Saharan Africa, North America, 
Central and South America, and South and Southeast Asia9.  This burden is brought on by social and 
biologic factors that leaves MSM epidemics continuously growing9.  HIV infection spreads quickly 
through networks of undiagnosed and untreated MSM.  A study in the UK found that in large MSM 




to the high HIV transmission probability of condomless receptive anal intercourse with a serodiscordant 
and viremic sexual partner, which is 11-18 times higher than that of condomless vaginal sex11,12.   
 MSM in Sub-Saharan Africa have been persistently ignored 13.  Many factors have converged to 
leave MSM neglected and at higher risk of infection than the general population in Africa.  Early reports 
of male-to-male HIV transmission were originally overlooked and disregarded14.  Knowledge and access 
to HIV prevention materials continues to be a problem in some regions13.  High-income settings often see 
interventions and treatment much faster than low and middle income countries4,15.  ART was not scaled 
up until between 2004 and 2007 in several African countries, such as Kenya, Malawi, Uganda and 
Tanzania, nearly a decade after the first treatments (protease inhibitors) were introduced in the United 
States in 199516,17.  A systematic review found that MSM in Africa were 3.8 times as likely to be living 
with HIV than reproductive-aged men5,18.  The stigma associated with being MSM also creates an 
environment wherein indiviudals do not disclose their sexual orientation to healthcare providers.  A study 
found that only 24% of MSM disclosed their MSM status to healthcare professionals in Batswana, while 
only 9% disclosed their status in Malawi19.  This inhibits these individuals from seeking necessary 
prevention and treatment services.  This is brought on by criminalization of homosexual behavior which 
hinders the ability to seek services and preventive measures20.  The high risk of transmission combined 
with a large disease burden and high levels of stigma creates a situation in which standalone interventions 
are not enough to curb the epidemic15. 
In Cameroon, there are an estimated 20,118 to 28,598 MSM living in the major urban centers, 
while 66,842 MSM are estimated to be living in the country21,22.  One study found that only a quarter of 
MSM had revealed their sexual orientation to a health care professional23.  HIV prevalence is estimated to 
be around 21% throughout the country while the prevalence among the general population in Cameroon is 
estimated to be 4.3%.  Approximately 10% of the MSM population in urban centers were unaware of 





While clinical trials have shown that PrEP can reduce incidence, modeling the outcomes of a prep 
intervention allows for interpretations of the effects at the population level.  One modeling study of 
female sex workers in Botswana, Kenya, and India demonstrated that PrEP would have a much greater 
impact on the number of prevented infections in Botswana and Kenya compared to India24. Another study 
modeling PrEP among MSM and transgender women in Peru found that low levels of PrEP coverage 
among high priority individuals could be cost-effective but would still require a large financial backing to 
implement25.   
While previous models have focused on PrEP use in heterosexual couples, combination 
intervention among MSM in South Africa, or PrEP on the MSM population in Peru, they have not 
addressed the dynamics of HIV in Cameroon among MSM25-27.  This model focuses specifically on 
transmission characteristics of HIV among MSM in Cameroon and the impacts of varied PrEP 




The mathematical model used here has been previously described28.  The model is intended to 
simulate HIV transmission among MSM in Cameroon with the ability to incorporate the impact of PrEP 
intervention.  This is a deterministic, compartmental model with 5 compartments; susceptible to infection 
(X), susceptible while on PrEP (XPrEP), infected but not diagnosed (IND), infected and diagnosed but not 
on treatment (ID), and infected, diagnosed and on treatment (IDT).  The model is represented in figure 1.  
The movement through compartments is determined by the rates at which people become 
infected, find out they are positive through testing, initiation or stop treatment, and initiate PrEP.  These 
are represented by the force of infection (), force of infection while on PrEP (PrEP), rate of PrEP 
initiation (), rate of HIV testing (), rate of ART initiation (), and rate of ART dropout (DT), Entry and 




(HIV_T).  Both of the force of infection parameters ( and PrEP) are based on two activity levels using the 
number of partners, the number of sex acts per partnership, and the per act transmission probability, 
outlined in table 1.  One key assumption made was that individuals on PrEP who became infected were 
aware of their HIV status within one year and therefore moved straight to the diagnosed compartment 
(ID).  Another assumption made was that this population did not actively participate in serosorting and 
therefore exhibited proportional mixing.  
 
Parameters 
 The model is parameterized by data collected in the 2016 Integrated Biological and Behavioral 
Surveillance (IBBS) survey among female sex workers and men who have sex with men in Cameroon 
(hereafter referred to as: IBBS 2016).  This survey is a cross-sectional study conducted among female sex 
workers and MSM throughout five major urban centers in Cameroon.  Participants were recruited through 
respondent driven sampling and trained interviewers gathered data through a behavioral questionnaire and 
serological testing.  For this model of HIV transmission in MSM, we only used the MSM data from this 
IBBS 2016.  When data was not available from this study we used data from similar areas throughout 
Central and Eastern Africa, summarized in Tables 1 and 2. 
In order to accurately parameterize the model, we used ranges from the IBBS 2016 survey to fit 
five of the model parameters and the three outcome parameters, the rest of the parameters were fit with 
point estimates for efficiency through IBBS 2016 or similar literature. All model parameters are outlined 
in table 1.  The outcome parameters were based on prevalence, rate of new diagnoses (per 100,000 MSM) 
and ART coverage over the past 10 years, and are outlined in Table 2. 
 
Calibration 
Calibration of this model was done using Latin Hypercube Sampling (LH) for the five model 
parameters with ranges in order to optimize the results from this model.  Using LH, each of the five 




sample of simulated epidemics, for a total of 105 simulations.  For every simulated epidemic, the value 
within each bin was sampled randomly within the ranges of that bin.  The model was run for 200 years to 
allow it to converge.  If the results of the epidemic fell within the ranges of all three outcome parameters; 
prevalence, new diagnoses, and ART coverage, outlined in table 2, they were kept for further analysis.  Of 
the simulated epidemics that fit the outcome parameters, maximum likelihood was tested of each outcome 
parameter. The maximum likelihood values for each outcome parameter were combined in even weights 
for each simulated epidemic to form a cumulative maximum likelihood value.  The parameter values from 
the simulated epidemic with the overall highest cumulative maximum likelihood was used to 
parameterize the original compartmental model. 
 
Intervention 
 After calibration, the original deterministic model was run.  First, it was run without any PrEP 
intervention to create a baseline from which the effects of PrEP could be drawn.  The effects were 
assessed by the change in prevalence and percent of prevented infections.  These were based on 1) 
different PrEP initiation rates over varied timeframes, 2) different PrEP coverage levels over a 20-year 
intervention , 3) the additional benefit of increased HIV testing due to PrEP intervention and 4) the effects 
of intervention on the proportion of individuals that are infected but undiagnosed.  Data calculations for 
the model and outcome parameters were done using STATA 14.2 (College Station, Texas).  The model 
was run and calibrated using MATLAB R2017b (9.3.0.713579) maci64.  Some figures were created using 




 The model was first calibrated over a 100-year timeframe but failed to converge so it was then 




simulations hit, wherein all three outcome parameters were satisfied.  Figure 2 is a graphical depiction of 
the final epidemic values after 200 years of running the model.  Maximum likelihood analyses resulted 
the combination of prevalence, annual diagnoses and ART coverage likelihood estimates with the 
cumulative maximum likelihood of 0.9936 (Figure 3).  The model parameters corresponding to the 
maximum likelihood of the outcome parameters are outlined in table 3.  The maximum likelihood model 
resulted in a prevalence of 16.4%, annual diagnoses of 946 per 100,000 MSM and an ART coverage of 
74.2%, after 200 years. 
 
Intervention 
 After running the model for 200 years, a standalone PrEP intervention was added to study the 
effects.  PrEP initiation of 5% and 10% of susceptible individuals per year resulted in an estimated 
prevalence of 14.1% and 12.6%, respectively, after 20 years of intervention compared to a baseline of 
16.4% (Figure 4).  These same initiation rates correspond to 13.8% and 22.6% of infections prevented 
over the 20-year intervention (Figure 5).  When increased to a 50-year intervention, the prevalence 
decreases to 11.1% and 8.4% for 5% and 10% PrEP initiation rates, while prevented cases over the same 
time period increases to 32.6 and 48.8%, respectively (Figure 5). 
 If PrEP interventions were implemented with a goal of 25%, 50% or 75% coverage at the end of a 
20-year intervention, the initiation rates per year would have to be 5.5%, 14.2% and 33.1%, respectively.  
Prevalence as a result of these programs would be 13.95%, 11.85%, and 9.95% after 20 years (Figure 6).  
The percent of infections prevented due to PrEP in these interventions would be 14.95%, 27.76% and 
39.32%.  Based on the percent of infections prevented per 1% initiation rate, the outcomes were 2.69%, 
1.95% and 1.88% cases prevented per unit of initiation for the 25%, 50% and 75% coverage 
interventions, respectively (Figure 7). 
 A PrEP initiation rate of 10% per year would result in a prevalence of 12.6% after 20-years, but if 
the HIV testing rate per year increased by 10% over the intervention, the prevalence would further reduce 




prevalence from 11.0% to 9.9% with an increase in HIV testing rate of 10% (Figure 10).  The increase in 
testing decreases the prevalence between year 0 and 5, but the effect size would remain relatively constant 
at a level of just over 1% for the duration of intervention. 
 With the benefits of additional testing, the proportion of undiagnosed cases per total infected 
would drop.  After a 20-year intervention with an initiation rate of 5% per year, the total number of 
infections would drop by 22.6% (Figure 8). Over the same intervention, the proportion of undiagnosed 
infections out of the total infections would drop from 15.6% at the start of the intervention to 9.7%.  
Combined with a 10% increase in testing, the percentage of undiagnosed cases would drop to 6.7% over 
the same timeframe.  A 20% initiation rate with a 10% increase in testing would change the proportion of 
unaware individuals from 15.6% to 4.2% over 20 years (Figure 8). 
 
Discussion 
The model converges after 200 years and PrEP intervention, at different lengths of time and 
levels of initiation, were added to the model with the possibility of incorporating an increased HIV testing 
rate.  The results from the PrEP intervention demonstrate that prevented infections would increase and 
HIV prevalence would decrease with an increase in the initiation rate of PrEP.  The greatest benefits 
would come from the highest levels of PrEP initiation, but the highest benefit, measured in infections 
prevented, to resource ratio would come at low levels of initiation and coverage.  Increased testing, as a 
result of the PrEP intervention, would result in a further increases to prevented cases and decreases in 
prevalence.  PrEP implementation would reduce the percentage of infected individuals that are 
undiagnosed. 
The model demonstrates the benefits to prevalence and prevented infections from a range of 
standalone PrEP interventions. But as Initiation rate of PrEP increases, the benefit decreases.  A study 
from South Korea showed that PrEP can reduce incidence of HIV among MSM as an independent 




found that PrEP was still beneficial29.  In this model, PrEP was able to reduce prevalence even at low 
levels of initiation. 
PrEP was scaled to reach different levels of coverage at the conclusion of a 20-year intervention, 
25%, 50% and 75% coverage.  The maximum cases averted per 1% initiation rate were found at the 25% 
coverage intervention.  Challenges, such as knowledge and attitude towards PrEP, may act as challenges 
in attempting to implement large PrEP interventions, making effective but modest interventions very 
appealing.  In 2014, MSM were interviewed about attitudes towards PrEP during a pride fair in Portugal.  
59% of MSM had not heard about PrEP, but of those that had, 57% responded that they were likely to use 
PrEP if made available30.  Similarly, in a review looking at studies between 2009 and 2016, the overall 
estimate of acceptability of oral PrEP was 56%20.  While positive perceptions of PrEP are likely to 
increase among MSM as exposure increases, it takes less resources to create programs that involve fewer 
individuals.  If PrEP is beneficial at low levels, it may be optimal to use small initiation rates and to scale 
up as demand increases, therefore saving resources while still preventing infections. 
The standalone intervention from the model prevented cases and reduced incidence of HIV, but a 
standalone intervention is not expected to end transmission of this infection.  Increased HIV testing 
should accompany any PrEP intervention since testing would likely be a prerequisite to starting PrEP for 
individuals that want to enroll31.  This model demonstrated that a 10% increase in testing could have large 
effects on the prevalence and could further prevent cases when acting in collaboration with a PrEP 
intervention (Figures 9 and 10).  A modeling study among MSM in South Africa showed that reducing 
the number of individuals that didn’t recieve an HIV test each year from 1/3 of the population to 1/6 
resulted in around a 5% increase in prevented infections27.  10% is a modest increase in HIV testing and 
the benefits would only be greater if testing increased more than 10%.  But, decreasing HIV prevalence 
and increasing the number of prevented infection are not the only impacts that increased testing would 
have on the results of the model.   
This PrEP intervention, and the increase in testing, would impact the percentage of individuals 




infection remain a crucial component to spreading HIV.  Studies have shown that those unaware of their 
HIV status have significant risks of onward HIV transmission32.  Individuals aware of their status have 
also been shown to be less likely to engage in condomless sex33-35.  One of the suggestions by the CDC in 




 There were several limitations in this study. First, Cameroon is a large country with several large 
cities with variable HIV transmission and prevalence, it may not be ideal to generalize the HIV 
transmission estimates to the entire countries when each city could have its own transmission 
characteristics.  Second, there are limited data within Cameroon and some of the model parameters were 
estimated from settings within the same region of West and Central Africa.  This led to limited precision 
in the outcome parameters, though they were based on data within the country.   
 
Conclusions 
This model shows that PrEP has the ability to reduce prevalence and prevent infections among 
MSM in Cameroon even at low levels of initiation and coverage.  Based on this model, the combination 
intervention of PrEP and increased HIV testing was able to, not only, reduce the prevalence of HIV, but 
also, decrease the percentage that are infected but unaware of their infection.  Reducing HIV transmission 
is a a slow process, but PrEP has a place among a suite of interventions that should be implemented.  
PrEP has the ability to limit HIV transmission in an area that has often been overlooked, among a 
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Model    
Parameter Symbol Range or value Source 
Proportion of high activity group NH/NL [0.05, 0.24] IBBS 2016, 37 
Ratio of number of partnerships high-activity 
group to low-activity group 
CH/CL [9, 27] IBBS 2016 
Transmission risk, receptive acts ßr [0.002, 0.025] 38 
HIV testing rate (per year)  [0.32, 0.64] IBBS 2016 
ART initiation rate (per year)  [0.57, 0.74] IBBS 2016 
Number of partners, low activity group CL 4 IBBS 2016 
condom use proportion,  
negative-negative 
pc11 0.77 IBBS 2016 
condom use proportion,  
positive-negative 
pc12 0.83 IBBS 2016 
Proportion of viral suppression among ART 
users 
TART 0.88 IBBS 2016 
Transmission risk, insertive acts ßi 0.0011 38 
ART dropout rate D 0.2 IBBS 2016 
Annual number of sex acts per partnership Nsa 23 IBBS 2016 
Condom efficacy dcondom 80% 39 
PrEP efficacy Ω 44% 6 
Entry/exit rate  0.026 IBBS 2016, 40 
Exit rate due to HIV mortality HIV 0.076 
16 
Exit rate due to HIV mortality while on ART HIV_T 0.031 
16 
Table 1. Model parameters.  The first five parameters: proportion of high activity group, ratio of number 
of partnerships of high-activity group to the low-activity group, transmission risk of receptive acts, HIV 
testing rate per year and ART initiation rate per year, all used ranges in the calibration.  The latter 





Parameter Range Source 
Prevalence 4-45% IBBS 2016 
Diagnoses (Annual diagnoses per 100,000 MSM) 23-1880 IBBS 2016, 22 
ART coverage 69-92% IBBS 2016, 23 
Table 2.  Outcome parameters.  Simulated epidemics within these bounds were kept for maximum 
likelihood calculations.  Diagnoses were calculated from the number of individuals who tested positive in 
a given year divided by the estimated MSM population in that area.  The low end was created when 1 
individual became HIV positive in Douala where the estimated MSM population is 4,438.  The upper end 
of the range came from Kribi, where 5 individuals were infected in a given year, where the MSM 






    
Parameter Symbol Range 
Maximum likelihood estimate 
values 
Proportion of high activity group NH/NL [5, 24] 0.06 
Ratio of number of partnerships CH/CL [9, 27] 11.5 
Transmission risk, receptive acts ßr [0.002, 0.025] 0.003 
HIV testing rate  [0.32, 0.64] 0.37 
ART initiation rate  [0.57, 0.74] 0.74 
Table 3 Model parameter results. Based on the cumulative maximum likelihood based on the Latin 






Figure 1. Model figure.  The compartments are: susceptible to infection (X), susceptible while on PrEP 
(XPrEP), infected but not diagnosed (IND), infected and diagnosed but not on treatment (ID), and infected, 
diagnosed and on treatment (IDT).  The rates of exchange between compartments are: the force of 
infection (), force of infection while on PrEP (PrEP), rate of PrEP initiation (), rate of HIV testing (), 
rate of ART initiation (), and rate of ART dropout (DT), Entry and exit rate not due to HIV (), exit rate 
while infected (HIV), and exit rate while infected and on treatment (HIV_T).  Individuals who are on PrEP 
(XPrEP) who become infected become aware of their HIV status within one year and therefore move to the 









Figure 2. All simulations.  Depicts a random sampling of the outcome parameters from the simulations 
that did not satisfy all three outcome parameters (open circles) with all simulations that did satisfy all 
outcome parameters (closed circles).  The gray rectangular prism depicts the range in which satisfied all 





Figure 3. Maximum likelihood of hits.  Depicts the simulations of epidemics that fit our outcome 





Figure 4. Prevalence over varied standalone interventions.  Prevalence based on a varied intervention 






Figure 5.  Percent cases averted over varied standalone PrEP interventions.  Percent of cases averted 







Figure 6. Prevalence from PrEP coverage interventions.  Prevalence at the end of a 20-year 





Figure 7. Change per effort for PrEP coverage interventions.  Change in prevalence per effort, 
measured as percent initiation rate of intervention in order to reach desired coverage.  Initiation rates were 





Figure 8.  Percent infected and unaware.  The percent infected who are undiagnosed out of total 







Figure 9. Prevented infections based on combination PrEP and test intervention.  Percent of cases 








Figure 10. Prevalence based on combination PrEP and test intervention.  Change in prevalence as an 
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